Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
43.02
0.00 (0.00%)
Jan 23, 2026, 4:00 PM EST - Market open
Artivion Employees
Artivion had 1,600 employees as of December 31, 2024. The number of employees increased by 100 or 6.67% compared to the previous year.
Employees
1,600
Change (1Y)
100
Growth (1Y)
6.67%
Revenue / Employee
$264,154
Profits / Employee
-$5,700
Market Cap
2.04B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,600 | 100 | 6.67% |
| Dec 31, 2023 | 1,500 | 200 | 15.38% |
| Dec 31, 2022 | 1,300 | 0 | - |
| Dec 31, 2021 | 1,300 | 100 | 8.33% |
| Dec 31, 2020 | 1,200 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 11,000 |
| AdaptHealth | 10,500 |
| QuidelOrtho | 6,600 |
| UFP Technologies | 4,146 |
| Tandem Diabetes Care | 2,650 |
| NovoCure | 1,488 |
| Inspire Medical Systems | 1,246 |
| Establishment Labs Holdings | 1,023 |
AORT News
- 27 days ago - Artivion Continues Building Toward Bigger And Better Things - Seeking Alpha
- 2 months ago - Alger Weatherbie Specialized Growth Fund Q3 2025 Portfolio Update - Seeking Alpha
- 2 months ago - Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Artivion Reports Third Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial - PRNewsWire
- 3 months ago - Artivion to Participate in the Stifel 2025 Healthcare Conference - PRNewsWire
- 3 months ago - Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PRNewsWire